• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童原发性免疫缺陷导致持续的 COVID-19 肺部感染。

Persistent COVID-19 lung infection in a child with a primary immunodeficiency.

机构信息

Departamento de Pediatría, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.

Facultad de Medicina, Universidad Nacional Federico Villarreal, Lima, Peru.

出版信息

BMJ Case Rep. 2021 Sep 14;14(9):e244768. doi: 10.1136/bcr-2021-244768.

DOI:10.1136/bcr-2021-244768
PMID:34521740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8442044/
Abstract

SARS-CoV-2 infection in children with primary immunodeficiency disease (PID) and its complications have not yet been well described, the course of COVID-19 can range from mild illness to death. We aim to report the case of a child with a PID who develop a severe and persistent pulmonary COVID-19 infection. We present chronologically his clinical course, tests, interventions and radiological findings showing his irregular evolution and poor response to infection. This case highlights the need to accurately monitor the immune response in these cases to try to stop the progression of the damage.

摘要

儿童原发性免疫缺陷病(PID)合并 SARS-CoV-2 感染及其并发症尚未得到充分描述,COVID-19 的病程范围从轻症到死亡。我们旨在报告一例 PID 儿童发生严重和持续的肺部 COVID-19 感染的病例。我们按时间顺序介绍他的临床过程、检查、干预措施和放射学发现,这些发现显示了他的病情演变不规则和对感染的反应不佳。这个病例强调了需要准确监测这些病例的免疫反应,以试图阻止损害的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/8442044/c778797a85d1/bcr-2021-244768f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/8442044/3c5f11233935/bcr-2021-244768f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/8442044/c313662cd436/bcr-2021-244768f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/8442044/c778797a85d1/bcr-2021-244768f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/8442044/3c5f11233935/bcr-2021-244768f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/8442044/c313662cd436/bcr-2021-244768f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5d/8442044/c778797a85d1/bcr-2021-244768f03.jpg

相似文献

1
Persistent COVID-19 lung infection in a child with a primary immunodeficiency.儿童原发性免疫缺陷导致持续的 COVID-19 肺部感染。
BMJ Case Rep. 2021 Sep 14;14(9):e244768. doi: 10.1136/bcr-2021-244768.
2
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.新冠疫情对以色列原发性免疫缺陷患者的临床影响较小。
Front Immunol. 2021 Jan 14;11:614086. doi: 10.3389/fimmu.2020.614086. eCollection 2020.
3
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
4
Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency.评估原发性免疫缺陷儿科患者的新型冠状病毒肺炎发病率及合成抗严重急性呼吸综合征冠状病毒2抗体的能力。
J Clin Med. 2021 Oct 30;10(21):5111. doi: 10.3390/jcm10215111.
5
Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.儿童和青少年风湿性肌肉骨骼疾病患者感染 SARS-CoV-2 的临床表现和结局:来自德国国家儿科风湿病数据库的数据。
RMD Open. 2021 Jul;7(2). doi: 10.1136/rmdopen-2021-001687.
6
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency.SARS-CoV-2 大流行对原发性免疫缺陷患者的影响。
J Clin Immunol. 2021 Feb;41(2):345-355. doi: 10.1007/s10875-020-00928-x. Epub 2020 Dec 1.
7
Follow-Up Analysis of Pulmonary Function, Exercise Capacity, Radiological Changes, and Quality of Life Two Months after Recovery from SARS-CoV-2 Pneumonia.新型冠状病毒肺炎康复两个月后肺功能、运动能力、影像学变化及生活质量的随访分析
Medicina (Kaunas). 2021 Jun 3;57(6):568. doi: 10.3390/medicina57060568.
8
Prospective cohort study of children with suspected SARS-CoV-2 infection presenting to paediatric emergency departments: a Paediatric Emergency Research Networks (PERN) Study Protocol.疑似 SARS-CoV-2 感染患儿就诊儿科急诊的前瞻性队列研究:儿科急诊研究网络(PERN)研究方案。
BMJ Open. 2021 Jan 15;11(1):e042121. doi: 10.1136/bmjopen-2020-042121.
9
Long-term clinical and serological follow-up of paediatric patients infected by SARS-CoV-2.儿童 SARS-CoV-2 感染者的长期临床和血清学随访。
Infez Med. 2021 Jun 1;29(2):216-223.
10
Lung ultrasound score to monitor COVID-19 pneumonia progression in patients with ARDS.肺部超声评分监测 ARDS 合并 COVID-19 肺炎患者的进展。
PLoS One. 2020 Jul 21;15(7):e0236312. doi: 10.1371/journal.pone.0236312. eCollection 2020.

引用本文的文献

1
Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.患有先天性免疫缺陷(原发性免疫缺陷)儿童的新型冠状病毒2型感染严重程度:一项系统评价
Allergy Asthma Clin Immunol. 2023 Aug 9;19(1):69. doi: 10.1186/s13223-023-00831-1.

本文引用的文献

1
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency.SARS-CoV-2 大流行对原发性免疫缺陷患者的影响。
J Clin Immunol. 2021 Feb;41(2):345-355. doi: 10.1007/s10875-020-00928-x. Epub 2020 Dec 1.
2
A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency.一例患有常见可变免疫缺陷的2019冠状病毒病致死病例。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):90-92. doi: 10.1016/j.anai.2020.08.017. Epub 2020 Aug 18.
3
Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?
新冠疫情中的原发性免疫缺陷疾病:是易感因素还是保护因素?
Am J Med Sci. 2020 Dec;360(6):740-741. doi: 10.1016/j.amjms.2020.07.027. Epub 2020 Jul 29.
4
Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.治愈的 COVID-19 患者在医学隔离观察期间出现 SARS-CoV-2 病毒 RNA 复阳。
Sci Rep. 2020 Jul 17;10(1):11887. doi: 10.1038/s41598-020-68782-w.
5
Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin.一名2019冠状病毒病患者在接受静脉注射免疫球蛋白治疗后出现阳性结果,该患者同时患有常见变异型免疫缺陷。
Ann Allergy Asthma Immunol. 2020 Sep;125(3):349-350. doi: 10.1016/j.anai.2020.06.006. Epub 2020 Jun 4.
6
[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].[关于针对冠状病毒的免疫反应的叙述性综述:概述、对SARS-CoV-2的适用性及治疗意义]
An Pediatr (Engl Ed). 2020 Jul;93(1):60.e1-60.e7. doi: 10.1016/j.anpedi.2020.04.016. Epub 2020 Apr 25.
7
Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective.针对免疫缺陷患者管理的抗SARS-CoV-2被动免疫的发展——一种观点。
J Allergy Clin Immunol. 2020 Jul;146(1):58-60. doi: 10.1016/j.jaci.2020.04.043. Epub 2020 May 12.
8
The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019.一名被诊断患有2019冠状病毒病的常见可变免疫缺陷患者的临床观察。
Ann Allergy Asthma Immunol. 2020 Jul;125(1):112-114. doi: 10.1016/j.anai.2020.04.033. Epub 2020 May 5.
9
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.两名 X 连锁无丙种球蛋白血症患者因 COVID-19 出现肺炎表现,但已康复。
Pediatr Allergy Immunol. 2020 Jul;31(5):565-569. doi: 10.1111/pai.13263. Epub 2020 May 19.